Financhill
Buy
66

NXST Quote, Financials, Valuation and Earnings

Last price:
$177.10
Seasonality move :
10.64%
Day range:
$174.55 - $179.47
52-week range:
$146.04 - $191.86
Dividend yield:
3.92%
P/E ratio:
8.22x
P/S ratio:
1.07x
P/B ratio:
2.39x
Volume:
2.6M
Avg. volume:
598.8K
1-year change:
5.66%
Market cap:
$5.4B
Revenue:
$5.4B
EPS (TTM):
$21.53

Earnings Data

Next earnings date for NXST
May 09
2025
Most recent earnings per share
$7.56
Missed by $0.46
(Feb 27/2025)
Consensus Estimate
$8.02
(Feb 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NXST Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/09/2025 Q1 $1.2B -- -- -- --
02/27/2025 Q4 $1.5B $1.5B $7.56 $8.02 -$0.46
11/07/2024 Q3 $1.4B $1.4B $5.27 $5.02 $0.25
08/08/2024 Q2 $1.3B $1.3B $3.54 $4.24 -$0.70
05/09/2024 Q1 $1.3B $1.3B $5.16 $3.72 $1.44
02/28/2024 Q4 $1.3B $1.3B $3.27 $3.71 -$0.44
11/08/2023 Q3 -- -- $0.70 $0.15 $0.55
08/08/2023 Q2 -- -- $2.64 $2.36 $0.28
05/09/2023 Q1 -- -- $2.97 $2.47 $0.50
02/28/2023 Q4 -- -- $5.30 $8.15 -$2.85
11/08/2022 Q3 -- -- $7.30 $5.69 $1.61
08/04/2022 Q2 -- -- $5.56 $4.90 $0.66
05/10/2022 Q1 -- -- $5.99 $4.31 $1.68
02/22/2022 Q4 -- -- $6.19 $4.91 $1.28
11/02/2021 Q3 -- -- $3.90 $4.04 -$0.14
08/04/2021 Q2 -- -- $4.51 $3.37 $1.14
05/04/2021 Q1 -- -- $4.42 $3.32 $1.11
02/23/2021 Q4 -- -- $7.97 $6.07 $1.90
11/05/2020 Q3 -- -- $4.08 $3.44 $0.64
08/05/2020 Q2 -- -- $2.13 $1.18 $0.95
05/06/2020 Q1 -- -- $3.30 $2.51 $0.79
02/26/2020 Q4 -- -- $2.36 $2.86 -$0.50
11/06/2019 Q3 -- -- -$0.13 $0.37 -$0.50
08/07/2019 Q2 -- -- $1.45 $1.33 $0.11
05/08/2019 Q1 -- -- $1.18 $0.98 $0.20
02/26/2019 Q4 -- -- $3.73 $3.42 $0.30
11/08/2018 Q3 -- -- $2.19 $2.00 $0.20
08/08/2018 Q2 -- -- $1.87 $1.66 $0.21
05/09/2018 Q1 -- -- $1.02 $0.97 $0.06
02/27/2018 Q4 -- -- $1.46 $1.38 $0.08
11/06/2017 Q3 -- -- $0.99 $0.96 $0.04
08/08/2017 Q2 -- -- $0.91 $0.76 $0.15
05/09/2017 Q1 -- -- $0.13 $0.19 -$0.06
02/28/2017 Q4 -- -- $1.46 $1.36 $0.10
11/08/2016 Q3 -- -- $0.78 $0.86 -$0.08
08/09/2016 Q2 -- -- $0.78 $0.83 -$0.05
05/03/2016 Q1 -- -- $0.69 $0.67 $0.02
02/25/2016 Q4 -- -- $0.86 $0.87 -$0.01
11/03/2015 Q3 -- -- $0.54 $0.56 -$0.02
08/06/2015 Q2 -- -- $0.63 $0.49 $0.14
05/07/2015 Q1 -- -- $0.40 $0.35 $0.05

Nexstar Media Group Earnings Questions

  • How Much did Nexstar Media Group Generate in Revenue Last Quarter?

    Nexstar Media Group reported $1.5B worth of top line sales in its most recent quarter.

  • Did Nexstar Media Group Beat Earnings Last Quarter?

    Nexstar Media Group announced earnings per share of $7.56 which represents a miss of analyst forecast a $8.02 per share.

  • Is Nexstar Media Group Profitable?

    Nexstar Media Group reported $929M that represents $29.55 per share over the last quarter.

  • What is the Analyst Consensus for Nexstar Media Group EPS Next Year?

    Nexstar Media Group's earnings are forecast to decrease from $21.41 per share to $17.14 per share next year representing a decrease of -19.94%.

  • When is Nexstar Media Group's Earnings Date?

    Nexstar Media Group's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock